Delivery Order SPE2DB22D3501-SPE2DB23FXC75
- Not listed
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BIKTARVY 50-200-25 MG TABLET to the Defense Logistics Agency (DLA). The award, valued at $97,947.83, is a Firm Fixed Price Delivery Order contract with a completion date of September 3, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also registered as a federal contractor. The contract does not have a set-aside designation,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $77,021.70 firm-fixed-price delivery order is for 4564450110 - BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,594.39 firm-fixed-price contract is for the delivery of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, with a completion date of October 25, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $54,991.16 for the supply of BIKTARVY 50-200-25 MG TABLET. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 11, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30s, with a ceiling value of $49,634.87 and a completion date of December 6, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30s. The award, valued at $40,281.54, is a firm fixed-price delivery order contract issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of November 20, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award, valued at $83,775.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of BIKTARVY 50-200-25 MG TABLET medical products, with an ultimate completion date of August 2, 2021. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 26, 2022. The $98,609.52 delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET medication. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,988.37 firm-fixed-price delivery order is for the supply of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET UU 30S, with a completion date of June 9, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,801.18 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has a performance period through May 10, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FXC75Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of BIKTARVY 50-200-25 MG TABLET. The $31,105.93 firm fixed-price delivery order has a completion date of September 6, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly supporting the Department of Defense (DOD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a $750,000 IDC with the Department of Justice Federal Bureau of Investigation, enabling the efficient procurement of essential pharmaceutical and medical supplies for federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.1k | 9/5/23 |